QRGenetics

AI-based Drug Discovery Engine for Genetic Diseases

Health Tech & Life Sciences
Active
Pre-Funding Tel Aviv-Yafo, Israel Founded 2019
Last updated 2026-06-18
Total raised
Last: Grant 2023-12
Stage
Pre-Funding
Founded
2019
Headcount
8
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

QRGenetics is the developer of a powerful AI-supported drug discovery engine designed to identify potential therapies for common genetic diseases by uncovering new treatments for patients with similar rare-disease mutations.

From Genetic disease without treatment or unknown MOA to precision medicine for populations and address patent cliffs QRGenetics develop a powerful AI-supported drug discovery engine that utilizes exclusive spatial analytics and proprietary datasets, to rapidly discover novel drug-target combinations prompting new applications for soon-expired drugs.

QRGenetics’ drug discovery engine utilizes exclusive spatial analytics and proprietary omics datasets to rapidly produce novel drug and target combinations that are effective for multiple indications.

Funding history · 1 round · — total

2023-12

Q&A

What is QRGenetics' primary focus?
QRGenetics is developing an AI-supported drug discovery engine to identify potential therapies for common genetic diseases by finding new treatments for patients with similar rare-disease mutations.
When was QRGenetics founded?
QRGenetics was founded in June 2019.
How many employees does QRGenetics currently have?
QRGenetics has 1-10 employees.
Who are the co-founders of QRGenetics?
The co-founders of QRGenetics are Shane Wald-Altman, Dan Lavi, and Miguel Weil.
What type of funding did QRGenetics receive in December 2023?
In December 2023, QRGenetics received a Grant, with Israel Investment Partners (IIP) listed as an investor.
What is QRGenetics' current funding stage?
QRGenetics is currently in the Pre-Funding stage.
In which sector does QRGenetics primarily operate?
QRGenetics' primary sector is Health Tech & Life Sciences.
What technologies does QRGenetics utilize in its drug discovery engine?
QRGenetics utilizes Artificial Intelligence, Deep Learning, Machine Learning, Biologicals, and Genes in its drug discovery engine.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Dan Lavi
Founder · Co-founder
Founder · Co-founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceDeep LearningMachine LearningBiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

patientsdeep-learninggenetic-disordersdiagnosticspharma-companiesdrug-discoverycardiovasculartreatmentsdecision-supportautomationrare-diseasesgeneticsdigital-healthcaretherapeuticspersonalizationartificial-intelligencepharmaceuticalsmachine-learningbiotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteqrgenetics.com
LinkedInlinkedin.com/company/30769932

Identifiers & details

Founded2019-6
Employees (exact)8

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainqrgenetics.com

Certificate / subdomain footprint

Subdomains5